← Back to Search

Not Applicable

Virtual Reality Gaming for Neuropathic Pain (VRWalk Trial)

N/A

Recruiting

Led By Zina Trost, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must be cleared on the VRWalk physical activity clearance scale

Recruitment of individuals with complete and incomplete injury (American Spinal Injury Association [ASIA] classification A, B, C, D) with lumbar, paraplegic, or low tetraplegic (C5-C7) injury

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at follow up (up to 18 months)

Awards & highlights

VRWalk Trial Summary

This trial will test if playing a VR walking game can help relieve neuropathic pain in adults with chronic spinal cord injury.

Who is the study for?

This trial is for adults over 18 with chronic spinal cord injury who have been experiencing significant neuropathic pain daily for at least three months. Participants should be stable on pain medication, able to move their elbows, and have a compatible mobile device. Those with motion sickness affecting daily life or blindness cannot join.Check my eligibility

What is being tested?

The study is testing whether playing one of two virtual reality walking games can reduce neuropathic pain in individuals with spinal cord injuries. It's designed to compare the effectiveness of these VR games in managing pain symptoms.See study design

What are the potential side effects?

While not explicitly listed, potential side effects may include dizziness, nausea related to VR use (commonly known as 'VR sickness'), eye strain, or headaches due to prolonged exposure to virtual environments.

VRWalk Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been cleared to participate in physical activities.

Select...

My spinal injury is classified as A, B, C, or D and is in the lumbar region or affects my arms and legs.

Select...

I am 18 years old or older.

Select...

It has been over a year since my injury.

Select...

I can lift my arms against gravity.

Select...

I have experienced nerve pain in the last week.

Select...

I have been on the same pain medication for at least a month.

Select...

I have had daily nerve pain rated at least 4 out of 10 for over 3 months.

VRWalk Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at follow up (up to 18 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at follow up (up to 18 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at follow up (up to 18 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Pain Intensity

Secondary outcome measures

Change in Pain Interference

Change in Pain Quality

Change in mood

+3 more

VRWalk Trial Design

2Treatment groups

Active Control

Group I: Virtual reality (VR) game 1Active Control1 Intervention

Participants will be asked to play a virtual reality game twice a day for 10 days.

Group II: Virtual reality (VR) game 2Active Control1 Intervention

Participants will be asked to play a virtual reality game twice a day for 10 days.

0 / 8Eligibility criteria met

Find a Location

Who is running the clinical trial?

Immersive Experience LabsUNKNOWN

1 Previous Clinical Trials

48 Total Patients Enrolled

1 Trials studying Neuropathic Pain

48 Patients Enrolled for Neuropathic Pain

McGuire Veterans HospitalUNKNOWN

Virginia Commonwealth UniversityLead Sponsor

699 Previous Clinical Trials

22,884,795 Total Patients Enrolled

3 Trials studying Neuropathic Pain

135 Patients Enrolled for Neuropathic Pain

Media Library

VR Game 1 (Not Applicable) Clinical Trial Eligibility Overview. Trial Name: NCT05005026 — N/A

Neuropathic Pain Research Study Groups: Virtual reality (VR) game 1, Virtual reality (VR) game 2

Neuropathic Pain Clinical Trial 2023: VR Game 1 Highlights & Side Effects. Trial Name: NCT05005026 — N/A

VR Game 1 (Not Applicable) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05005026 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this research project currently open?

"As per the information on clinicaltrials.gov, this trial is in its active recruitment phase. It was first posted on November 23rd 2021 and the most recent edit was made to it's details on March 21st 2022."

Answered by AI

May I take part in this experiment?

"In order to be eligible for this trial, applicants must have suffered a spinal cord injury and fit within the age demographic of 18-65. The total participation goal is 250 patients."

Answered by AI

What is the aggregate participation rate in this clinical experiment?

"Indeed, information available on clinicaltrials.gov affirms that this medical trial is currently recruiting participants. It was first posted to the website on November 23rd 2021 and has had its most recent update on March 21st 2022. An approximate total of 250 patients are being sought from 1 specific site for enrollment in the study."

Answered by AI